12-21560468-T-C

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_021957.4(GYS2):​c.1087A>G​(p.Met363Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.782 in 1,572,172 control chromosomes in the GnomAD database, including 482,680 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.75 ( 42603 hom., cov: 32)
Exomes 𝑓: 0.79 ( 440077 hom. )

Consequence

GYS2
NM_021957.4 missense

Scores

1
17

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 2.80
Variant links:
Genes affected
GYS2 (HGNC:4707): (glycogen synthase 2) The protein encoded by this gene, liver glycogen synthase, catalyzes the rate-limiting step in the synthesis of glycogen - the transfer of a glucose molecule from UDP-glucose to a terminal branch of the glycogen molecule. Mutations in this gene cause glycogen storage disease type 0 (GSD-0) - a rare type of early childhood fasting hypoglycemia with decreased liver glycogen content. [provided by RefSeq, Dec 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=7.3008766E-7).
BP6
Variant 12-21560468-T-C is Benign according to our data. Variant chr12-21560468-T-C is described in ClinVar as [Benign]. Clinvar id is 261462.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-21560468-T-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.777 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GYS2NM_021957.4 linkc.1087A>G p.Met363Val missense_variant Exon 8 of 16 ENST00000261195.3 NP_068776.2 P54840
GYS2XM_024448960.2 linkc.1087A>G p.Met363Val missense_variant Exon 8 of 17 XP_024304728.1
GYS2XM_006719063.4 linkc.856A>G p.Met286Val missense_variant Exon 7 of 15 XP_006719126.1
GYS2XM_017019245.3 linkc.1087A>G p.Met363Val missense_variant Exon 8 of 9 XP_016874734.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GYS2ENST00000261195.3 linkc.1087A>G p.Met363Val missense_variant Exon 8 of 16 1 NM_021957.4 ENSP00000261195.2 P54840
ENSG00000285854ENST00000647960.1 linkn.*1089A>G non_coding_transcript_exon_variant Exon 15 of 23 ENSP00000497202.1 A0A3B3IS95
ENSG00000285854ENST00000647960.1 linkn.*1089A>G 3_prime_UTR_variant Exon 15 of 23 ENSP00000497202.1 A0A3B3IS95
ENSG00000285854ENST00000648372.1 linkn.1014A>G non_coding_transcript_exon_variant Exon 8 of 11

Frequencies

GnomAD3 genomes
AF:
0.746
AC:
113390
AN:
151966
Hom.:
42566
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.677
Gnomad AMI
AF:
0.631
Gnomad AMR
AF:
0.741
Gnomad ASJ
AF:
0.689
Gnomad EAS
AF:
0.752
Gnomad SAS
AF:
0.797
Gnomad FIN
AF:
0.810
Gnomad MID
AF:
0.604
Gnomad NFE
AF:
0.782
Gnomad OTH
AF:
0.684
GnomAD3 exomes
AF:
0.770
AC:
193463
AN:
251334
Hom.:
74829
AF XY:
0.770
AC XY:
104600
AN XY:
135832
show subpopulations
Gnomad AFR exome
AF:
0.670
Gnomad AMR exome
AF:
0.788
Gnomad ASJ exome
AF:
0.690
Gnomad EAS exome
AF:
0.749
Gnomad SAS exome
AF:
0.792
Gnomad FIN exome
AF:
0.807
Gnomad NFE exome
AF:
0.778
Gnomad OTH exome
AF:
0.733
GnomAD4 exome
AF:
0.786
AC:
1115961
AN:
1420088
Hom.:
440077
Cov.:
27
AF XY:
0.785
AC XY:
556918
AN XY:
709100
show subpopulations
Gnomad4 AFR exome
AF:
0.676
Gnomad4 AMR exome
AF:
0.783
Gnomad4 ASJ exome
AF:
0.694
Gnomad4 EAS exome
AF:
0.784
Gnomad4 SAS exome
AF:
0.792
Gnomad4 FIN exome
AF:
0.804
Gnomad4 NFE exome
AF:
0.793
Gnomad4 OTH exome
AF:
0.756
GnomAD4 genome
AF:
0.746
AC:
113485
AN:
152084
Hom.:
42603
Cov.:
32
AF XY:
0.749
AC XY:
55721
AN XY:
74358
show subpopulations
Gnomad4 AFR
AF:
0.677
Gnomad4 AMR
AF:
0.742
Gnomad4 ASJ
AF:
0.689
Gnomad4 EAS
AF:
0.752
Gnomad4 SAS
AF:
0.795
Gnomad4 FIN
AF:
0.810
Gnomad4 NFE
AF:
0.782
Gnomad4 OTH
AF:
0.686
Alfa
AF:
0.768
Hom.:
84460
Bravo
AF:
0.736
TwinsUK
AF:
0.794
AC:
2945
ALSPAC
AF:
0.792
AC:
3052
ESP6500AA
AF:
0.676
AC:
2980
ESP6500EA
AF:
0.777
AC:
6680
ExAC
AF:
0.768
AC:
93297
Asia WGS
AF:
0.755
AC:
2622
AN:
3478
EpiCase
AF:
0.763
EpiControl
AF:
0.752

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Glycogen storage disorder due to hepatic glycogen synthase deficiency Benign:4
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Aug 10, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

May 28, 2019
Mendelics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:3
Mar 03, 2015
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Oct 23, 2015
Mayo Clinic Laboratories, Mayo Clinic
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.042
BayesDel_addAF
Benign
-0.72
T
BayesDel_noAF
Benign
-0.66
CADD
Benign
14
DANN
Benign
0.80
DEOGEN2
Benign
0.22
T
Eigen
Benign
-1.1
Eigen_PC
Benign
-0.70
FATHMM_MKL
Benign
0.14
N
LIST_S2
Benign
0.59
T
MetaRNN
Benign
7.3e-7
T
MetaSVM
Benign
-0.93
T
MutationAssessor
Benign
-3.2
N
PrimateAI
Uncertain
0.60
T
PROVEAN
Benign
2.6
N
REVEL
Benign
0.19
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Polyphen
0.0
B
Vest4
0.081
MPC
0.12
ClinPred
0.0018
T
GERP RS
4.0
Varity_R
0.059
gMVP
0.55

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2306180; hg19: chr12-21713402; COSMIC: COSV53923853; API